The Global Antiviral Drugs Market size is expected to reach USD 50.02 Billion in 2030 and register a revenue CAGR of 3.4% during the forecast period, according to latest report by Reports and Data. Increasing number of patients infected by influenza and other viral respiratory infections, especially during the COVID-19 pandemic, is driving market revenue growth. Many factors are contributing to this rapid spread of viral infectious diseases, including increasing human mobility, rise in trade and tourism, and shifting geographic distribution of disease vectors.
Human travel and migration, in particular, is a major driving force behind the global spread of viral infections. Changing environmental conditions, due to abrupt climate change, is also contributing to widespread viral infections, and this is resulting in development of novel antiviral medications, which is supporting market revenue growth. However, high costs of Research & Development (R&D) in the area of drug development is limiting market revenue growth. Furthermore, rising healthcare costs and preventive measures against viral infections are also expected to hinder revenue growth of the market during the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/1734
The pharma and healthcare sector has significantly advanced in the recent years and is expected to register steady revenue growth over the forecast period owing to rapid innovations in medical technology, increasing investments, rising healthcare expenditure and high adoption of advanced products and systems. Factors such as rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders across the globe, rising cases of coronavirus, improving healthcare infrastructure and research facilities, and increasing adoption of remote patient monitoring services and home care settings are expected to fuel global market revenue growth over the forecast period. In addition, increasing number of hospitals and ambulatory care centers worldwide, high demand for personalized medicine, increasing investments in drug discovery and growing investments by public and private sectors are expected to drive global market growth in the coming years.
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Antiviral Drugs market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Pfizer Inc., and Dr. Reddy’s Laboratories Ltd.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1734
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Antiviral Drugs Market Segmentation:
Drug Type Outlook (Revenue, USD Billion; 2019-2030)
- Generic Drugs
- Branded Drugs
Application Outlook (Revenue, USD Billion; 2019-2030)
- Hepatitis A, B & C
- Human Immunodeficiency Virus (HIV)
- Respiratory Syncytial Virus (RSV)
- Human Coronaviruses (HCoV)
Mechanism of Action Outlook (Revenue, USD Billion; 2019-2030)
- Protease Inhibitors
- DNA Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Neuraminidase Inhibitors
Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)
- Hospital Pharmacy Services
- Online Pharmacy Services
- Retail Pharmacy Services
Geographic Segment Covered in the Report:
The Antiviral Drugs report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)
Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/antiviral-drugs-market
Key market aspects are illuminated in the report:
- Executive Summary: It covers a summary of the most vital studies, the Global Antiviral Drugs market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
- Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Antiviral Drugs market, the years measured, and the study points.
- Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
- Manufacture by Region: This Global Antiviral Drugs report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1734
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.